CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.

Explore this paper's citation graph

Summary

The rapidly developing CRISPR/Cas9-based technologies for disease modeling and gene correction and recent progress toward Cas9/guide RNA (gRNA) delivery based on viral and nonviral vectors are reviewed.

Type
review
Published
2017-06-22
Cited by
489
References
299

Keywords

CRISPR, Genome editing, Cas9, Guide RNA, Computational biology

References

Cited by

Related papers